Holocene Advisors, LP Edwards Lifesciences Corp Call Options Transaction History

Holocene Advisors, LP

3 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2022 May 16, 2022	BUY	$101.96 - $128.34 $43.3 Million - $54.5 Million	424,600 Added 152.19%	703,600 $82.8 Million
Q3 2021 Nov 15, 2021	SELL	$102.91 - $122.75 $34.3 Million - $40.9 Million	-333,500 Reduced 54.45%	279,000 $31.6 Million
Q2 2021 Aug 16, 2021	BUY	$83.84 - $104.76 $51.4 Million - $64.2 Million	612,500 New	612,500 $63.4 Million

1,417

470M

2.44M

2.65M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $41.2B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Holocene Advisors, LP, based on Form 13F filings with the SEC.

Stay updated on Holocene Advisors, LP with notifications on news.